Intranasal Peptide Delivery: 5 Key Bioavailability Factors Explained
Introduction Intranasal peptide delivery has gained significant attention as a non-invasive alternative to traditional injection methods. Therapeutic peptides typically have poor oral availability due to enzymatic degradation and low gastrointestinal absorption, so parenteral administration (especially subcutaneous injection) has been the mainstay for systemic delivery. In recent decades, intranasal delivery has emerged as a route that […]






